Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-25-023646
Filing Date
2025-11-14
Accepted
2025-11-14 17:21:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5488
  Complete submission text file 0001493152-25-023646.txt   7134
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Subject) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-80718 | Film No.: 251488282
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O DYADIC INTERNATIONAL, INC. 140 INTRACOASTAL POINT DRIVE, SUITE 404 JUPITER FL 33477-5094
Business Address
EMALFARB MARK A (Filed by) CIK: 0001328287 (see all company filings)

Type: SCHEDULE 13G/A